Physician profile
Thomas E Burns
NPI 1003896903
$9,353.08
in general payments reported to CMS, 2019-2025
60 companies · $2,114 in 2025
The $2,114 reported for 2025 was more than what 81% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,074 · 2020: $669 · 2021: $648 · 2022: $1,816 · 2023: $1,499 · 2024: $1,533 · 2025: $2,114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,146.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,315.55 | 2019-2025 | Xtandi |
| Olympus America INC. | $641.55 | 2021-2025 | Itind System, Soltive, Soltive |
| Boston Scientific Corporation | $504.66 | 2019-2025 | Spaceoar Vue System - 10ml, Ams 700, Axonics |
| Bayer Healthcare Pharmaceuticals INC. | $457.66 | 2019-2025 | |
| Coloplast Corp | $428.07 | 2019-2025 | Coloplast Tfl Drive, Speedicath |
| Verity Pharmaceuticals INC. | $377.29 | 2022-2025 | Trelstar, Tlando |
| Axonics, INC. | $363.67 | 2020-2023 | Axonics, Bulkamid |
| Janssen Biotech, INC. | $360.93 | 2019-2025 | Erleada |
| Abbvie INC. | $358.42 | 2022-2025 | Botox |
| Myriad Genetic Laboratories, INC. | $310.38 | 2022-2025 | Prolaris |
| Sumitomo Pharma America, INC. | $302.54 | 2023-2025 | Orgovyx, Gemtesa |
| Neotract INC. | $292.78 | 2019-2020 | |
| Endo USA, INC. | $226.73 | 2024-2025 | Xiaflex, Aveed |
| Procept Biorobotics Corporation | $207.26 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Merck Sharp & Dohme LLC | $204.60 | 2020-2025 | Keytruda, Lynparza |
Show all 60 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Burns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.